Titelia

Fund shareholders of Syros Pharmaceuticals Inc

ISIN US87184Q2066 · United States · LEI 549300512PURS7IGVT96

Fund shareholders
1
Of which ETFs
0 1 other fund
Value held
0.2 $

A single tracked fund declares this company. So these figures do not say who owns it.

FundSharesValueWeight in fund
Diversified Equity Master Portfolio Master Investment Portfolio 8700.2 $as of Mar 31, 2026 ↗

Download this table: CSV, JSON

Report an error

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q2108700.0 %
2026Q1108700.0 %
2025Q4108700.0 %
2025Q31-4870-99.5 %
2025Q25-5168,752-64.9 %
2025Q110-7481,301-62.8 %
2024Q417-21,294,958-1.6 %
2024Q319+11,316,608+7.3 %
2024Q218+11,226,831+25.3 %
2024Q117-3979,170+26.5 %
2023Q420774,194
Cite this page

Titelia. "Fund shareholders of Syros Pharmaceuticals Inc". https://titelia.com/en/stocks/syros-pharmaceuticals-inc-US87184Q2066